Featured Product In Regulatory Affairs
Using Real-World Evidence in Drug and Device Submissions
$397.00
Acquire insights into the ideal RWE/RWD data to use in your product applications today with Using Real-World Evidence in Drug and Device Submissions. Read More
Regulatory Affairs
Latest Medical Device Postmarket Surveillance Requirements from China’s NMPA and the U.S. FDA – Webinar Recording/Transcript
$287.00
Data Integrity for Drug and Device Manufacturers: Avoiding Breaches and Closing Gaps
$129.00
Data Integrity in the COVID-19 Era and Beyond — Part III: The Real-World Costs of Data Integrity – Virtual Conference Recording/Transcript
$287.00
